We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 16.25 | 16.00 | 16.50 | 16.25 | 16.25 | 16.25 | 3,472 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0125 | -13.00 | 36.74M |
Date | Subject | Author | Discuss |
---|---|---|---|
19/11/2024 21:48 | ‘ Commercial terms finalised on the basis of claims from additional studies’ What claims ? What studies ? ‘ As previously announced, the results of the additional studies were all very positive’ Yeah but what claims are made of the skinbiotix ingredient ? 19th Sept ‘ The conclusions of its studies are all positive although no details will be released publicly’ Oh ….why is that? ‘due to the highly sensitive and competitive nature of the cosmetics market…..̵ Oh,,,,will it be marketed in secret then ? ‘ Obviously, the metrics and specifics from the study won't be released publicly since this is highly commercially sensitive information that belongs to Croda.’ Oh, it belongs to Croda. Oh well | kreature | |
19/11/2024 21:38 | What does the skinbiotix ingredient do ? ‘ Under the terms of the agreement, all details about formulation, functionality… Why? ‘due to the competitiveness of the cosmetics market.’ Oh yeah, that’s believable | kreature | |
19/11/2024 21:35 | ‘ the product is now in the marketing and commercialisation phase’ ‘ Under the terms of the agreement, all details about formulation, functionality and Croda's financial expectations remain confidential due to the competitiveness of the cosmetics market.’ Contradiction? | kreature | |
19/11/2024 21:00 | Maybe……. | kreature | |
19/11/2024 16:50 | Maybe its rub on plastic surgery | putinaire | |
19/11/2024 16:44 | There must be some health or beauty claims, otherwise what’s the point of it | kreature | |
19/11/2024 16:29 | I've no idea really. Very confused messaging and anything that would clarify is a secret May as well not exist unless selling shares | putinaire | |
19/11/2024 16:27 | What health claims are being made for new skinbiotix ingredient? Does it still reverse time? | kreature | |
19/11/2024 16:26 | Shareholders there must be informed 'Of the new revolution ' | putinaire | |
19/11/2024 16:25 | And it's a concluded deal? Need to address that too directly | putinaire | |
19/11/2024 16:24 | Croda needs a dressing down from the regulator I think. As bad as uni's and uni doctors Maybe they haven't made the claim at all ? Croda must say something directly to market Surely it is market sensitive re a pending magic ingredient | putinaire | |
19/11/2024 16:19 | I suppose they don’t want any competitor to duplicate the ingredient just from Croda acknowledging the success and existence of the ingredient in a press conference? Someone might be able to duplicate the ingredient if they see it ? | kreature | |
19/11/2024 16:17 | Which independent auditing science body was used to confirm the successful findings anyway? Or do we just have to believe yet another story ? The secrecy surely demands this profession give an audit report re not the details. Just validate the claims for market | putinaire | |
19/11/2024 16:08 | Yes very true. Imaginary product outlooks are best left to imaginary business's Should be a press conference within 24 hours of a release, to maximise sales Share sales | putinaire | |
19/11/2024 16:06 | Croda would probably be unable to comment on imaginary projects…̷ | kreature | |
19/11/2024 16:06 | I can imagine. Lol | putinaire | |
19/11/2024 16:04 | I expect there will be some very tough questions during the fireside chat. | kreature | |
19/11/2024 16:02 | When is the Croda press conference? Will it be in their upcoming 'product outlooks' rag | putinaire | |
19/11/2024 15:59 | "Stuart Ashman, CEO of SkinBioTherapeutics will be discussing the recent news flow in a "fireside chat"" Didn't opti make clear in an rns what newsflow was about re PBX re share price manipulation lol Disappointed. The RNS is completely empty Only served one purpose. Maker can dump out a bit higher for clients | putinaire | |
19/11/2024 15:52 | Putinaire - 18 Nov 2024 - 17:21:35 - 20404 of 20434 Not that the RNS or podcast makes market. It just gives the maker something to walk it up lol ... Didn't take long for sellers to appear. Financials must be close 😂 | putinaire | |
19/11/2024 15:47 | Be no point knowing the CEO. We all probably knew before he did | putinaire | |
19/11/2024 15:46 | Wow. Either Putin knows the dark game or knows the CEO and had inside info. | ming da merciless |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions